BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register

DRUG

Bright Minds Biosciences Inc. NASDAQ Listed Mar 22, 2021
$60.98
-0.93% vs $61.55
Mkt Cap $596.8M
52w Low $48.90 16.1% of range 52w High $123.75
50d MA $73.74 200d MA $77.91
P/E (TTM)
EV/EBITDA
P/B 5.1x
Debt/Equity 0.0x
ROE
P/FCF -48.3x
RSI (14) 22.10
ATR (14) $2.87
Beta -0.11
50d MA $73.74
200d MA $77.91
Avg Volume 115.3K
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
SIC Code
2834
CIK (SEC)
Phone
647 407 2515
1500 – 1055 West Georgia Street · New York City, BC V6E 4N7 · CA
Data updated apr 25, 2026 5:48am · Source: financialmodelingprep.com